Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Delee Corp
Delee Corp. offers the CytoCatch™ technology, a duo of systems designed for the efficient isolation and analysis of circulating tumor cells (CTCs). The CytoCatch™ Isolation Platform utilizes a…
Delee Corp
Delee Corp. offers the CytoCatch™ technology, a duo of systems designed for the efficient isolation and analysis of circulating tumor cells (CTCs). The CytoCatch™ Isolation Platform utilizes a…
TL;DR
Product: CytoCatch™ isolation and imaging platform for circulating tumor cells (CTCs)
Founded: 2017
Headquarters: San Francisco, California, United States
Employees: 11
Reported funding: ≈ $2.37M (public entries) and reported > $2.4M on Dealroom
Company Overview
Problem Domain
Diagnostics / oncology — circulating tumor cell isolation, imaging, and analysis for early detection and treatment monitoring
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
Most recent round listed publicly as Seed on Jan 1, 2023
Investor Signal
“Backed by accelerators including Y Combinator and StartX Med; investors reported include Bay Wharf Capital and The Ganesha Lab”